James A M Shaw
Overview
Explore the profile of James A M Shaw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
733
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kattner N, Hang Y, Krentz N, Krentz N, Russell L, Palmer M, et al.
J Endocrinol
. 2025 Jan;
264(3).
PMID: 39836539
Endocrine dysfunction and diabetes can develop secondary to fibrotic diseases within the pancreas, including cystic fibrosis (CF). A phenotypic shift within epithelial cells has been recognised in association with pro-fibrotic...
2.
Ralston J, Anderson M, Ng J, Bashir A, Ehrlich K, Burns-Hunt D, et al.
Contemp Clin Trials
. 2025 Jan;
149:107767.
PMID: 39765436
No abstract available.
3.
Lin Y, Ye W, Hepworth E, Rickels M, Amiel S, Speight J, et al.
J Clin Endocrinol Metab
. 2024 Dec;
PMID: 39657003
Context & Objective: Sparse large-scale studies have characterized hypoglycemia symptomatology in adults with type 1 diabetes (T1D) who use continuous glucose monitoring (CGM). This research aimed to evaluate the relationship...
4.
Bashir A, Joseph N, Hammond J, White S, Abu-El-Haija M, Drewes A, et al.
Pancreas
. 2024 Dec;
54(3):e268-e277.
PMID: 39626176
Objectives: This scoping review aims to provide evidence synthesis of continuous glucose monitoring (CGM) and insulin pump use after undergone total pancreatectomy (TP) with or without islet autotransplantation (TPIAT). Methods:...
5.
Lin Y, Ye W, Hepworth E, Agni A, Matus A, Flatt A, et al.
Diabetologia
. 2024 Oct;
68(2):433-443.
PMID: 39477881
Aims/hypothesis: We aimed to: (1) externally validate the five-item Hypoglycaemia Awareness Questionnaire (HypoA-Q) impaired awareness subscale (HypoA-Q IA); (2) examine how impaired awareness of hypoglycaemia (IAH) relates to the risk...
6.
Halliday J, Holmes-Truscott E, Thuraisingam S, Soholm U, Chatterton M, Russell-Green S, et al.
Trials
. 2024 Oct;
25(1):725.
PMID: 39468682
Background: Management of type 1 diabetes (T1D) requires the use of insulin, which can cause hypoglycaemia (low blood glucose levels). While most hypoglycaemic episodes can be self-treated, all episodes can...
7.
Westholm E, Karagiannopoulos A, Kattner N, Al-Selwi Y, Merces G, Shaw J, et al.
iScience
. 2024 Sep;
27(9):110767.
PMID: 39280605
Intra-islet crosstalk has become a focus area to fully understand the regulation of insulin secretion and impaired β-cell function in type 2 diabetes (T2D). Here, we put forward evidence for...
8.
9.
Nielsen B, Mathiesen I, Krogh-Madsen R, Katzenstein T, Pressler T, Shaw J, et al.
Diabetologia
. 2024 Aug;
67(10):2188-2198.
PMID: 39093413
Aims/hypothesis: The aim of this study was to investigate insulin secretion, insulin sensitivity, disposition index and insulin clearance by glucose tolerance status in individuals with cystic fibrosis (CF) and exocrine...
10.
Bashir A, Flatt A, Richell G, Shaw J
Diabet Med
. 2024 Jun;
41(9):e15389.
PMID: 38927008
Aims: The HypoCOMPaSS multi-centre trial achieved improvement in hypoglycaemia awareness and 20-fold reduction in severe hypoglycaemia (SH) in a cohort with long-standing type 1 diabetes (T1D). All participants received 'my...